Dentists in Portola, CA Accepting Medicare
3 Dentists found. Showing 1 - 3
 Derry L. Hildebrand Jr., D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 296 W Sierra Ave., Ste 1, Portola, CA 96122 Phone: 530-832-0200 Fax: 530-832-0900 |
Dr. Bruce H Lee, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 181 S Gulling St, Portola, CA 96122 Phone: 530-832-4461 |
Dr. Mario G. Garibotti, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 145 N Pine St, Portola, CA 96122 Phone: 530-832-4425 Fax: 530-832-1058 |
News Archive
Lawmakers join state exchanges ahead of tough 2014 election battles
Some Washington lawmakers are joining their home state insurance marketplaces ahead of 2014's elections so they can say they are getting the same health law choices as constituents.
WHO says Asian states too slow in reporting bird flu
The regional director for the World Health Organisation (WHO) in the Western Pacific has complained that Asian countries take too long to report some human cases of bird flu and this could hamper any efforts to contain a possible pandemic.
BMJ examines why India's dengue epidemic continues to grow
This BMJ feature examines why India's dengue epidemic continues to grow worse each year, stating, "In the past decade, according to the National Vector Borne Disease Control Programme (NVBDCP), the number of cases has escalated steadily from 3,306 in 2001 to 47,209 in 2012," and "[d]eaths have risen from 53 in 2001 to 242 in 2012."
Surgeons: Support your low-income neighbor
Patients with cancer in low-income nations present for surgical treatment at a young age, advanced stage of disease, and often receive palliative rather than curative procedures, suggests a study in Malawi.
CTI announces positive results from Phase I-II pixantrone combination study against INHL
Cell Therapeutics, Inc. announced the publication of results posted in the online journal of Cancer of a Phase I-II study that evaluated the safety and efficacy of pixantrone when used in combination with fludarabine, dexamethasone and rituximab replacing mitoxantrone in the standard FND-R regimen with FPD-R among 28 patients with relapsed or refractory indolent non-Hodgkin's lymphoma.
› Verified 4 days ago